Trends in HPV vaccination among adults aged 27–45 years in the United States
ABSTRACT Despite expanded human papillomavirus (HPV) vaccination recommendations via shared clinical decision-making (SCDM) for adults aged 27–45 years (i.e., mid-adults), uptake remains low in the United States. Examining trends in HPV vaccination under SCDM across sociodemographic groups, vaccination sites, provider...